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Migraines and Myocardial Infarction in Women 
Abstract 
Background: Heart disease is the number 1 cause of death for U.S. women, myocardial infarction (MI) 
included. It has been established that ischemic stroke has a positive correlation with those who 
experience migraines, but there were no definitive studies saying that migraines cause all other 
cardiovascular related diseases, even though there is a common consensus that migraines are a vascular 
phenomenon. This systematic review focuses on the correlation between migraines and myocardial 
infarction particularly in women. 
Methods: An exhaustive search of available medical literature was conducted using MEDLINE-Ovid, Web 
of Science, and CINAHL databases. The following terms were searched as keywords: migraine, 
myocardial infarction, and women or female. Studies applicable to the topic of the association of 
migraines and myocardial infarction in women were included as long as they were in English, on human 
subjects, and prospective cohort studies. The quality of relevant articles was evaluated via the GRADE 
Working Group guidelines. 
Results: The initial search yielded 193 articles that were narrowed down to 3 prospective cohort studies 
by applying the eligibility criteria. Each study yielded odds ratios of having a MI in women with migraines 
compared to women without migraines. The Kurth et al, WHS, resulted in the hazard ratios of 1.94 (95% CI 
1.27 to 2.95, P value 0.002) for active migraine with aura. The Kurth et al, NHS II, had an age adjusted 
hazard ratio of 1.79 (95% CI 1.52 to 2.10, P value 
Conclusion: Women who have migraines, especially those with aura, are at an increased risk of 
myocardial infarction compared to those without migraines. Providers should consider migraines in 
women as a positive risk factor for myocardial infarction. These findings should prompt research on the 
biological process of migraines and whether the treatments we use now can protect women from the 
increased risk. 
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Abstract 
Background: Heart disease is the number 1 cause of death for U.S. women, 
myocardial infarction (MI) included. It has been established that ischemic stroke 
has a positive correlation with those who experience migraines, but there were no 
definitive studies saying that migraines cause all other cardiovascular related 
diseases, even though there is a common consensus that migraines are a vascular 
phenomenon. This systematic review focuses on the correlation between 
migraines and myocardial infarction particularly in women.  
Methods:  An exhaustive search of available medical literature was conducted 
using MEDLINE-Ovid, Web of Science, and CINAHL databases. The following 
terms were searched as keywords: migraine, myocardial infarction, and women 
or female. Studies applicable to the topic of the association of migraines and 
myocardial infarction in women were included as long as they were in English, on 
human subjects, and prospective cohort studies. The quality of relevant articles 
was evaluated via the GRADE Working Group guidelines.  
Results:  The initial search yielded 193 articles that were narrowed down to 3 
prospective cohort studies by applying the eligibility criteria. Each study yielded 
odds ratios of having a MI in women with migraines compared to women without 
migraines. The Kurth et al, WHS, resulted in the hazard ratios of 1.94 (95% CI 
1.27 to 2.95, P value 0.002) for active migraine with aura. The Kurth et al, NHS 
II, had an age adjusted hazard ratio of 1.79 (95% CI 1.52 to 2.10, P value <0.01) 
for overall migraineurs. And the Bigal et al, AMPP, had odds ratios of 2.32 (95% 
CI 1.63–3.31, P value <0.01) for migraines overall, 3.52 (95% CI 2.38–5.19, P 
value <0.01) for MA, and 1.75 (95% CI 1.19–2.58, P value <0.01) for MO. 
Conclusion:  Women who have migraines, especially those with aura, are at an 
increased risk of myocardial infarction compared to those without migraines. 
Providers should consider migraines in women as a positive risk factor for 
myocardial infarction. These findings should prompt research on the biological 
process of migraines and whether the treatments we use now can protect women 
from the increased risk. 
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 Migraines are a common disorder that affects 18% of U.S. women.1 
Migraines present as a severe, usually unilateral headache often with the 
associated symptoms of nausea, vomiting, dizziness, sensitivity to light, sound, 
touch, and smell. The headaches usually last between 4 to 72 hours. Migraines 
can also have a perceptual disturbance called an aura that precedes the headache. 
The aura can come in many forms: visual disturbances (flashing lights, blind 
spots, difficulty focusing), auditory disturbances (fullness in the ear, tinnitus, 
pressure), weakness or tingling of the face or limbs, or coordination problems.  
 Migraines have previously been established to be an increased risk factor 
for ischemic stroke.2 Migraines have also been speculated to be a risk factor for 
overall cardiovascular disease including myocardial infarction (MI), also known 
as a heart attack. The pathophysiology of migraines is not fully understood, but 
there is a common consensus that it is a vascular phenomenon. Many studies3,4,5 
have researched the association of migraines with major cardiovascular disease 
risk only within some cardiovascular risk groups or for certain vascular events. 
This review specifically looks at women and their risk for myocardial infarction in 
association with migraines.  
Because heart disease is the leading cause of female deaths in the U.S.6 it 
would be beneficial for providers to know whether women with migraines are 
having more MIs than those without migraines. Providers could use this 
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information when calculating a female patient’s risk for heart disease and 
predicting future heart attacks. This knowledge may drive providers to treat 
patients they may have otherwise overlooked and could save a life.  
METHODS 
 A comprehensive literature search using MEDLINE-Ovid, Web of Science, 
and the Cumulative Index of Nursing and Allied Health Literature (CINAHL) was 
conducted. The following search terms were used: “migraine,” “myocardial 
infarction,” and “women or female.” The bibliographies from relevant 
background articles were used and eligibility criteria were applied. The quality of 
relevant articles was evaluated using the Grading of Recommendations 
Assessment, Development and Evaluation (GRADE) working group guidelines.7 
Inclusion Criteria 
 Included were studies conducted on women who had migraines compared 
to a control group of women who did not experience migraines. Additionally, 
these studies had to have compared the specific cardiovascular event of 
myocardial infarction in their data set. Other inclusion criteria required human 
studies and studies published in the English language.  
Exclusion Criteria 
 Studies were excluded if researchers did not dissect out myocardial 
infarction from other cardiovascular events such as stroke and claudication. 
Studies that related specific migraine pharmacology treatment to myocardial 
infarction were excluded as well. In addition, case series and case control studies 
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were omitted due to their inherently low quality results for a prognosis question. 
Lastly, only the primary study from a data set was included while all secondary 
studies were excluded from the search. 
RESULTS 
 The initial search yielded 193 articles for review. After eliminating 
duplicates and screening these results for relevancy to the search terms there 
were 39 articles to further analyze. Using the eligibility criteria, there were 3 
articles that answered the clinical question. All 3 articles8,10,11 are prospective 
cohort studies. (See Table 1.) 
Kurth et al, WHS 
 This is an article on a prospective cohort study called the Women’s Health 
Study (WHS)8 conducted by Harvard Medical School and Brigham and Women’s 
Hospital. The women in this study were US female health professionals, ≥45 
years old. Baseline information was collected by self-reported questionnaires that 
were mailed to the participants. The follow-up information was also collected via 
mailed questionnaires twice in the first year, 1993, and yearly thereafter through 
March 2007. The questionnaires asked about cardiovascular risk factors, 
personal characteristics, medical history, and health habits. At the start, there 
were 27 519 women participants all free of cardiovascular disease at baseline, 
with a 97% follow-up of the cohort.8 
 Assessment of migraine was based off the baseline questionnaire. The 
WHS had reported good agreement of self-reported migraine compared to the 
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1988 International Headache Society criteria for migraine. The results of the 
questionnaires categorized women into “no migraine” (n=22 445), “prior 
migraines” (n=1497), “active migraines with aura” (n=1418), and “active 
migraines without aura” (n=2159). The distinction of prior migraines and active 
migraines was whether the participant had a migraine within the previous year 
before the initial questionnaire.8  
 The primary outcome of the WHS was major cardiovascular disease events 
measured by myocardial infarction, ischemic stroke, and death via cardiovascular 
events. The WHS also categorized their data according to the well-known 
Framingham risk score.9 The result reviewed for this study was the secondary 
outcome of myocardial infarction. The results of myocardial infarction were 
obtained via medical records, specifically the record of abnormal cardiac enzymes 
or abnormal electrocardiographic results indicative of an MI. The study resulted 
in the hazard ratios of 1.94 (95% CI 1.27–2.95, P value 0.002) for active migraine 
with aura, 0.95 (95% CI 0.58–1.56, P value 0.85) for active migraine without 
aura, and 1.20 (95% CI 0.76–1.89, P value 0.44) for prior migraines. These are 
the overall results of the women studied. The only significant result of the 
Framingham risk groups was those with active migraine with aura and a 
Framingham risk score ≥10%; resulting in a hazard ratio of 3.34 (95% CI 1.50–
7.46, P value 0.003).8,9 
Kurth et al, NHS II 
 This was a prospective cohort study from the Nurses’ Health Study II10 
conducted by Brigham and Women’s Hospital, Harvard Medical School, and 
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Harvard T.H. Chan School of Public Health. This was a cohort of women from the 
ages 25-42 years old at baseline who were followed from 1989 through June 2011. 
The NHS II began with a baseline questionnaire and follow-up questionnaires 
every two years through 2011. The participants were all female nurses in the 
United States that were free of angina or any other cardiovascular disease at the 
start.10  
The study began with 115 541 women and had more than a 90% follow-up 
rate. There were 17 531 women in the study who reported physician-diagnosed 
migraine at baseline in 1989 and an extra 6389 women reported a new, 
physician-diagnosed migraine during the study time frame; only the women with 
a migraine diagnosis at baseline were included in the statistical analysis.10  
 The primary outcome of the study was major cardiovascular disease that 
was measured as a cumulative endpoint of myocardial infarction, stroke, and 
fatal cardiovascular disease. Only the measured secondary endpoint of 
myocardial infarction was investigated. During the follow-up, 678 myocardial 
infarctions occurred. Compared with women without migraines, those with self-
reported physician-diagnosed migraines had an age adjusted hazard ratio of 1.79 
(95% CI 1.52–2.10, P value <0.01) for experiencing a myocardial infarction.10  
Bigal et al, AMPP 
 Bigal et al11 is an article on the prospective cohort study called the 
American Migraine Prevalence and Prevention (AMPP) study conducted by the 
National Headache Foundation. Participants were 18-69 years old and were 
categorized by sex, 10 year increments of age, and race. The study began in 2004 
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with a randomization of 120 000 U.S. households. The participants were given 
the validated self-administered questionnaire used by the WHS (same 
questionnaire discussed in Kurth et al, WHS). Five years later a cohort of 24 000 
migraine sufferers and 10 000 controls without headaches were resurveyed for 
the primary outcomes of myocardial infarction, stroke, and claudication. All 
outcomes were verified by medical record, including myocardial infarction.11  
 The migraineurs were counted overall as well as into the categories of 
migraine with aura (MA) and migraines without aura (MO). Odds of having an 
MI compared to those without migraines, women with any type of migraine have 
the odds ratios of 2.32 (95% CI 1.63–3.31, P value <0.01), with MA 3.52 (95% CI 
2.38–5.19, P value <0.01), and with MO 1.75 (95% CI 1.19–2.58, P value <0.01).11  
 The follow-up rates were 67% for migraineurs and 52.4% for controls. The 




 Heart disease is the number one killer of women across the United States. 
Of that, coronary heart disease, including myocardial infarction, is the greatest.6 
If there was a way that could better predict and prophylactically treat the risk 
factors for heart disease, specifically myocardial infarction it should be utilized. 
This is already being done in many ways by treating the known risk factors of 
hypertension, diabetes, obesity, hypercholesterolemia, and smoking. What if 
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migraines were also on that list of risk factors for women? Would this encourage 
clinicians to monitor cardiovascular risks in women with migraines? Would this 
urge practitioners to prophylactically treat migraines more aggressively? 
Additionally would it prompt researchers to further study the mechanism of 
migraines and discover whether the treatments used today are sufficient to 
reduce the risk of MIs?  
This systematic review was able to uncover three studies8,10,11 that look at 
the effect of migraines on the occurrence of MIs in women. In synthesizing the 
results from the three prospective cohort studies, the consensus was that women 
with migraines do show an increase in the occurrence of myocardial infarction. 
This was true for all data sets with statistical significance and could potentially be 
more than double the risk for an MI, especially in those women with aura 
associated to their migraine.  
As seen in Table 2, the Kurth et al, NHS II,10 represented the lowest 
association with an age-adjusted OR of 1.79 (1.52 to 2.10) for MIs compared to 
women without migraines. The highest overall association was in the Bigal et al, 
AMPP,11 with an OR of 2.32 (1.63 to 3.31) for MIs compared to women without 
migraines. The Kurth et al, WHS,8 fell between these two with an OR for MA of 
1.94 (1.27 to 2.95) for MIs. In collaborating these studies, it is apparent that there 
is an increase correlation between MIs and female migraineurs.  
Further dissecting these studies, the Kurth et al, WHS,8 categorized their 
data into Framingham risk score groups.9 The only Framingham risk score9 
group that had statistical significance was the group of women with a risk score 
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≥10% and active migraines with aura. This group’s OR was even higher than any 
of the figures discussed earlier, with an OR of 3.34 (1.50 to 7.46). This may 
indicate that women with a higher 10-year cardiovascular disease risk are 
impacted even more so by a history of migraines. 
The Bigal et al, AMPP,11 additionally sub-categorized their data into MA 
and MO, as did Kurth et al, WHS.8 The Kurth et al, WHS,8 had data without 
statistical significance (P value >0.05) for MO and “prior migraines.” This lack of 
statistical significance is not surprising since the study only had 24 participants 
who experienced an MI. The values from the category of “active migraine with 
aura” was statistical significant represented by the P value of 0.002. As far as 
Bigal et al, AMPP,11 the participants with MA had an OR of 3.52 (2.38 to 5.19) 
while those with MO had the OR of 1.75 (1.19 to 2.58). This may suggest that 
women with MA represent a greater MI risk than those with MO.  
The odds ratios shown here are between 1.75 and 3.52, representing a 
positive correlation between migraines and MIs in women. Looking at the big 
picture, 2.6 million U.S. women have MIs in their lifetime and about 18% of U.S. 
women have migraines.12  This would implicate that thousands if not 10s of 
thousands of women with migraines could experience an associated myocardial 
infarction in the US alone.  
Limitations of Study 
 These studies were evaluated using the GRADE method7 and results can 
be seen in Table 1. The major limitation of all three studies is that they are 
observational studies. Observational studies do not allow for as much control of 
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other factors that may play into the correlation between migraines and MIs, 
therefore it is not possible to draw a cause-effect relationship, merely just a 
correlation.  
 Another limitation is within the Bigal et al, AMPP study.11 This study had 
incomplete follow-up with a response rate of 67% in the migraines group and 
52.4% in the control group; however, the article states that the demographics 
between the responders and non-responders “did not significantly differ”.11 The 
original article shows that response rate was higher in white participants that 
were greater than 50 years old. The older age of responders may have caused a 
change of incidence due to age rather than migraine history.  
 The Kurth et al, WHS,8 and the Kurth et al, NHS II,10 obviously have the 
same primary author; who is also a secondary author on the Bigal et al, AMPP, 
article.11 This may represent a bias in the display of information although each of 
the studies had many additional authors and are based off separate cohort/data 
sets. 
Further research should address whether or not migraine history warrants 
screening and managing other cardiovascular risk factors. More information 
regarding migraine pathology would help to inform clinicians and researchers of 
possible shared mechanisms with myocardial infarctions and result in strategies 
for interventions.  Lastly, it is unknown if migraine prophylaxis will reduce the 
patient’s risk for myocardial infarction. 
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CONCLUSION 
 The leading cause of death of women in the United States is cardiovascular 
disease, including myocardial infarction. This systematic review resulted in a 
positive correlation between migraines and myocardial infarction in women. The 
review of three prospective cohort studies in total representing women from 18 to 
69 years old across the US exhibited a potential doubling of the occurrence of 
myocardial infarctions compared to women without migraines, especially those 
with an aura.  
 The implication for practice is whether migraines should be a risk factor 
considered in the prophylactic management of cardiovascular disease in women. 
Furthermore, continuous research would be helpful to know whether the current 
migraine management prescribed is protective against the risk of myocardial 
infarction, and whether this treatment should be used more aggressively. 
Research on a more in-depth pathophysiologic understanding of migraines would 
be beneficial to potentially develop a protective treatment if the current 
treatment is not protective.  
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bias 




Not serious Not serious Not serious Not serious Unlikely None Low 






Not Serious Not serious Not serious Unlikely None Low 









a Bigal et al study only had a follow up of 67% in the target group and 52.4% in the control group 
b Bigal et al had an odds ratio greater than 2 
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ORa (95% CI) 
Migraine with 
aura with MI 
ORa (95% CI) 
Migraine with 
aura and FRS of 
≥10% with MI 
ORa (95% CI) 
Migraine without 
aura with MI 
ORa (95% CI) 
Kurth et al 
(WHS) 
24 (1.69) -------- 1.94 (1.27 – 2.95) 3.34 (1.50 – 7.46) -------- 
Kurth et al 
(NHS II) 
678 (3.87) 1.79 (1.52 – 2.10) -------- -------- -------- 
Bigal et al 
(AMPP) 
314 (6.40) 2.32 (1.63 – 3.31) 3.52 (2.38 – 5.19) -------- 1.75 (1.19 – 2.58) 
Abbreviations: CI – confidence interval, OR – odds ratio 
All P values are ≤0.05 
aAll ORs are vs control (women without migraines) 
